Ajinomoto Bio-Pharma Services India Private Limited - Company Profile

It is a pharma private limited company based in Anakapalle, Andhra Pradesh, India, established in 2011.

2011 Anakapalle, Andhra Pradesh, India Active

Last Updated: March 06, 2026

About Ajinomoto Bio-Pharma Services India Private Limited

Ajinomoto Bio-Pharma Services India Private Limited, a active private limited company, was established on 02 September 2011 in Anakapalle, Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233AP2011PTC117217. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹95.00 Cr and a paid-up capital of ₹85.76 Cr.

Formerly known as Granules Omnichem Private Limited. It upholds a compliant status. Employing 159 professional, Its leadership includes Patrick Juliaan E De Craene (Director), Venkata Viswanadha Raju Kakarlapudi (Managing Director), Els Roeland (Director). Past directors included Venkata Satyanarayana Murthy Vadali, Mark Adam Cassidy, Patrick Juliaan E De Craene. It holds no open charges and ₹185.20 Cr settled loans. Its latest AGM occurred on 12 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.121 (Part) &122, Visakha Pharma City Limited, Sez, Parawada, Lankelapalem, Anakapalle, Andhra Pradesh, 531019.

Company Details

CIN/LLPIN
U24233AP2011PTC117217
Registration Number
117217
Incorporation Date
02 September 2011
Authorized Capital
₹95.00 Cr
Paid-Up Capital
₹85.76 Cr
ROC Code
Roc Vijayawada
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 95.00 Cr as on 06-03-2026
Paid Up Capital ₹ 85.76 Cr as on 06-03-2026
Company Age 14 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 185.20 Cr as on 06-03-2026
Revenue Growth **** -36.29% (FY 2023)
Profit Growth **** -148.71% (FY 2023)
Ebitda **** -42.92% (FY 2023)
Net Worth -5.42% (FY 2023)
Total Assets **** 49.33% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Ajinomoto Bio-Pharma Services India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ajinomoto Bio-Pharma Services India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Patrick Juliaan E De Craene	Director	10 Jun 2021	Current
Venkata Viswanadha Raju Kakarlapudi	Managing Director	29 May 2020	Current
Els Roeland	Director	09 Mar 2023	Current
Kristof Laura H Van Belleghem	Director	22 May 2025	Current
Wouter Maria F Biesmans	Director	22 May 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	20 Sep 2017	Past
Pramod Abcsdd	Additional Director	20 Aug 2020	Past
Pramod Abcsdd	Additional Director	18 Jun 2021	Past
Pramod Abcsdd	Director	07 Dec 2021	Past
Pramod Abcsdd	Ceo(Kmp)	28 Jun 2022	Past
Pramod Abcsdd	Nominee Director	29 May 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ajinomoto Bio-Pharma Services India.

Ajinomoto Bio-Pharma Services India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.29% decrease. The company also saw a substantial fall in profitability, with a 148.71% decrease in profit. The company's net worth dipped by a decrease of 5.42%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-36.29%

*******

Revenue from Operations

*******

-34.38%

*******

Total Assets

*******

49.33%

*******

Profit or Loss

*******

-148.71%

*******

Net Worth

*******

-5.42%

*******

EBITDA

*******

-42.92%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ajinomoto Bio-Pharma Services India?

In 2023, Ajinomoto Bio-Pharma Services India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹1,852,000,000.00

Charges Breakdown by Lending Institutions

Deg - Deutsche Investitions - Und Entwicklungsgesellschaft Mbh : 62.10 Cr
Ing Bank Nv Singapore Branch : 62.10 Cr
Others : 61.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
13 Oct 2016	Others	₹61.00 Cr	Satisfied
23 Apr 2013	Deg - Deutsche Investitions - Und Entwicklungsgesellschaft Mbh	₹62.10 Cr	Satisfied
23 Apr 2013	Ing Bank Nv Singapore Branch	₹62.10 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ajinomoto Bio-Pharma Services India?

Ajinomoto Bio-Pharma Services India has a workforce of 159 employees as of Sep 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ajinomoto Bio-Pharma Services India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajinomoto Bio-Pharma Services India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ajinomoto Bio-Pharma Services India

Recent Activity within the Organization

Annual General Meeting

Progress on Ajinomoto Bio-Pharma Services India Private Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records. was documented.
12 Sep 2025
Director Appointment

Kristof Laura H Van Belleghem was appointed as a Director was appointed as a Director on 22 May 2025 & has been associated with this company since 9 months 21 days . was recorded as a recent event.
22 May 2025
Director Appointment

Wouter Maria F Biesmans was appointed as a Director was appointed as a Director on 22 May 2025 & has been associated with this company since 9 months 21 days . was recorded as a recent event.
22 May 2025
Balance Sheet

Progress on Ajinomoto Bio-Pharma Services India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was documented.
31 Mar 2025
Director Appointment

Els Roeland was appointed as a Director was appointed as a Director on 09 Mar 2023 & has been associated with this company since 3 years 4 days . was recorded as a recent event.
09 Mar 2023
Director Appointment

Srivenkata Subrahmanya Sarma Kuchi was appointed as a Cfo was appointed as a Cfo on 28 Jun 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
28 Jun 2022

Explore recent activity and updates - View Recent Activity